Tumor-Pulsed Dendritic Cells Used as a Tumor Vaccine
Clinical trial NCT00176761 · TERMINATED
Trial details
- NCT number
- NCT00176761
- Sponsor
- University of Michigan Rogel Cancer Center
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2000-03-01
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.